nybanner

        Products

        API-Drug Peptide BPC157 Pentadecapeptide Intestinal Peptide Promote regeneration and healing

        Short Description:

        BPC 157 is a native gastric pentadecapeptide that is nontoxic and has profound cytoprotective activity; it has been used in ulcerative colitis and multiple sclerosis trials.


        Product Detail

        Product Tags

        About This Item

        In human gastric juice, BPC 157 is stable for more than 24 hours, and thus it has good oral bioavailability (always given alone) and beneficial effects in the entire gastrointestinal tract . This is an important distinction from the otherstandard peptides, which are functionally dependent on theaddition of carrier or are otherwiserapidly destroyed in human gastric juice.Consequently, stable BPC 157 is suggested to be a mediator of Robert’s cytoprotection, which maintains the integrity ogastrointestinal mucosa. We suggest that the contribution of BPC 157 to Robert’s cytoprotection – that is, the ability to counteract fundamental alcohol-induced gastric lesions, which Robert called cytoprotection – and the ability to counteract lesions arising from the direct injurious contact of the noxious agent with the cell represent the peripheral connection between the gut and the brain axis.

        Perovic reported that BPC 157 has a marked therapeutic effect pertaining to the recovery of rats with a spinal cord injury with tail paralysis (1-minute compression injury of the sacrocaudal spinal cord [S2–Co1]). Specifically, a single intraperitoneal BPC 157 administration at 10 minutes post-injury counteracts the negative effects. By contrast, the spinal cord injury and tail paralysis persist in untreated rats, assessed days, weeks, months, and a year after the injury. Of note, BPC 157 attenuates the commonly caused damage . Thereby, BPC 157 therapy results in evident functional, microscopic, and electrophysiologic recovery .

        Product Dispaly

        IMG_20200609_154048
        IMG_20200609_155449
        IMG_20200609_161417

        Why Choose Us

        Of note, in rats with spinal cord injury, there is permanent reperfusion. Once BPC 157 is administered 10 minutes post-compression injury, there is continuous protection and no spontaneous spinal cord injury-induced disturbances reappear.All spinal cord injuries immediately provoke hemorrhage, with subsequent death of neurons and oligodendrocytes.

        Hence, it is conceivable that early hemostasis may be beneficial and enable functional recoveryafter spinal cord contusion in rats. However, the effect exerted by BPC 157 is likely different from the simple hemostatic effect that would attenuate spinal cord injury, because BPC 157 also markedly improves thrombocyte function in rats without affecting coagulation factors. During recovery from spinal cord injury, BPC 157 also directly protects the endothelium, alleviates peripheral vascular occlusion disturbances, rapidly activates alternative bypass pathways, and counteracts venous occlusion–induced syndromes. Thus, assuming that there is a substantial venous contribution to the spinal cord compression, it is conceivable that the reestablished blood flow mediated by BPC 157 may undoubtedly contribute to the rapid recovery effect. Furthermore, considering that BPC 157 promotes permanent reperfusion after spinal cord compression, it should be noted that when BPC 157 is given during reperfusion, it counteracts stroke induced by bilateral clamping of the common carotid arteries. BPC 157 resolves neuronal damage and prevents memory, locomotor, and coordination deficits. BPC 157 apparently exerts these effects by altering gene expression in the hippocampus .

        In conclusion, BPC 157 exerts beneficial effects on stroke, schizophrenia, and spinal cord injury .
        Researchers have consistently demonstrated that BPC 157 exerts a myriad of beneficial effects throughout the body. There is no reason to indicate that the benefits of BPC 157 are limited by the validity of the utilized models and/or methodology limitations. Indeed, we can argue that the effectiveness, easy applicability, safe clinical profile and mechanism of BPC 157 represent an alternative, likely successful, future therapeutic direction for neurological conditions. Therefore, additional studies are needed to clarify how potential BPC 157 therapy would specifically deal with a mechanism of action that involves multiple subcellular sites in the CNS. The influence on the function of most, if not all, neuronal systems at the molecular, cellular, and systemic levels should be explored. Some visceral repetitive relay of the CNS or circumventricular organs, one of the few regions in the brain without the blood-brain barrier, is a known pathway by which a systemically administered peptide can exert a central effect. Thus, it must act within the gut-brain axis, regardless of whether this action is direct or indirect.


      1. Previous:
      2. Next:

      3. 主站蜘蛛池模板: 日韩精品卡二卡3卡四卡| 精品黑人一区二区三区| 天堂精品高清1区2区3区| 国产国产精品人在线视| 99精品国产第一福利网站| 欧美成人第一页| 国产在线精品一区二区不卡麻豆| chinese乱子伦xxxx视频播放| 欧美性a欧美在线| 北美伦理电线在2019| 911亚洲精品| 日韩一区二区三区无码影院| 又大又硬又爽免费视频| 色偷偷女男人的天堂亚洲网| 好想吃你的馒头| 久久久久琪琪去精品色无码| 欧美叉叉叉BBB网站| 俄罗斯乱理伦片在线观看| 色婷婷综合久久久| 国产欧美一区二区三区久久 | 大伊香蕉在线观看视频wap| 亚洲免费网站在线观看| 草莓视频在线观| 天堂а√在线官网| 丰满少妇被猛男猛烈进入久久| 欧美三级蜜桃2在线观看| 人间**电影8858| 美女尿口免费影视app| 国产喷水女王在线播放| 18av在线视频| 成年女人永久免费观看片| 亚洲av无码一区二区三区鸳鸯影院| 漂亮人妻被黑人久久精品| 国产成人a毛片在线| 一级毛片直接看| 欧美变态柔术ⅹxxx另类| 任我爽精品视频在线播放| 美女高潮黄又色高清视频免费| 国产精品视频免费一区二区| www.激情小说| 日韩美香港a一级毛片|